This content is PDF only. Please click on the PDF icon to access.
To the rheumatologist, the term "second-line agent" refers to a class of drugs used in treatment of rheumatoid arthritis when aspirin and nonsteroidal anti-inflammatory drugs (first-line) have failed. Second-line agents include gold, hydroxychloroquine, D-penicillamine, azulfidine, azathioprine, and methotrexate. Cyclosporine is still experimental, and studies with FK506 are just being initiated. With regard to systemic lupus erythmatosus and vasculitis, a "second agent," usually an immunosuppressant, is often required when corticosteroids alone are inadequate.
How can yet another discussion of these drugs justify more than 600 pages of text at a cost of $165.00? The answer is simple: there is no way.
Learn more about subscription options.
Register Now for a free account.
Second-Line Agents in the Treatment of Rheumatic Diseases. Ann Intern Med. 1992;117:542. doi: 10.7326/0003-4819-117-6-542_4
Download citation file:
Published: Ann Intern Med. 1992;117(6):542.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only